<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">Modulation of insulin degrading enzyme activity and liver cell proliferation</title>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability status="unknown"><licence/></availability>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author role="corresp">
							<persName><forename type="first">Olga</forename><surname>Pivovarova</surname></persName>
							<email>olga.pivovarova@dife.de</email>
							<affiliation key="aff0">
								<orgName type="department">Department of Clinical Nutrition</orgName>
								<orgName type="institution">German Institute of Human Nutrition Potsdam-Rehbruecke</orgName>
								<address>
									<settlement>Nuthetal</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff1">
								<orgName type="department">Department of Endocrinology, Diabetes and Nutrition</orgName>
								<orgName type="institution">Charit e University Medicine</orgName>
								<address>
									<addrLine>Campus Benjamin Franklin</addrLine>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Christian</forename><surname>Von Loeffelholz</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Department of Clinical Nutrition</orgName>
								<orgName type="institution">German Institute of Human Nutrition Potsdam-Rehbruecke</orgName>
								<address>
									<settlement>Nuthetal</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff2">
								<orgName type="department" key="dep1">Integrated Research and Treatment Center</orgName>
								<orgName type="department" key="dep2">Center for Sepsis Control and Care</orgName>
								<orgName type="institution">Friedrich Schiller University</orgName>
								<address>
									<settlement>Jena</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff3">
								<orgName type="department">Department of Anesthesiology and Intensive Care</orgName>
								<orgName type="institution">Jena University Hospital</orgName>
								<address>
									<settlement>Jena</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff4">
								<orgName type="department">German Center for Diabetes Research</orgName>
								<address>
									<settlement>Neuherberg</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Iryna</forename><surname>Ilkavets</surname></persName>
							<affiliation key="aff5">
								<orgName type="department" key="dep1">Molecular Hepatology -Alcohol Associated Diseases</orgName>
								<orgName type="department" key="dep2">Faculty of Medicine Mannheim at</orgName>
								<orgName type="institution" key="instit1">Medical Clinic II</orgName>
								<orgName type="institution" key="instit2">Heidelberg University</orgName>
								<address>
									<settlement>Mannheim</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff6">
								<orgName type="department">Heidelberg Institute for Theoretical Studies</orgName>
								<orgName type="laboratory">Scientific Databases and Visualization</orgName>
								<address>
									<settlement>Heidelberg</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Carsten</forename><surname>Sticht</surname></persName>
							<affiliation key="aff7">
								<orgName type="department" key="dep1">Center for Medical Research</orgName>
								<orgName type="department" key="dep2">Faculty of Medicine Mannheim at</orgName>
								<orgName type="institution">Heidelberg University</orgName>
								<address>
									<settlement>Mannheim</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Sergei</forename><surname>Zhuk</surname></persName>
							<affiliation key="aff8">
								<orgName type="department">Institute of Molecular Biology and Genetics</orgName>
								<orgName type="institution">Almazov Federal Heart, Blood and Endocrinology Center; Saint-Petersburg</orgName>
								<address>
									<country key="RU">Russia</country>
								</address>
							</affiliation>
							<affiliation key="aff9">
								<orgName type="institution">Institute of Molecular Biotechnology GmbH</orgName>
								<address>
									<settlement>Vienna</settlement>
									<country key="AT">Austria</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Veronica</forename><surname>Murahovschi</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Department of Clinical Nutrition</orgName>
								<orgName type="institution">German Institute of Human Nutrition Potsdam-Rehbruecke</orgName>
								<address>
									<settlement>Nuthetal</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff1">
								<orgName type="department">Department of Endocrinology, Diabetes and Nutrition</orgName>
								<orgName type="institution">Charit e University Medicine</orgName>
								<address>
									<addrLine>Campus Benjamin Franklin</addrLine>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Sonja</forename><surname>Lukowski</surname></persName>
							<affiliation key="aff5">
								<orgName type="department" key="dep1">Molecular Hepatology -Alcohol Associated Diseases</orgName>
								<orgName type="department" key="dep2">Faculty of Medicine Mannheim at</orgName>
								<orgName type="institution" key="instit1">Medical Clinic II</orgName>
								<orgName type="institution" key="instit2">Heidelberg University</orgName>
								<address>
									<settlement>Mannheim</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Stephanie</forename><surname>D€ Ocke</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Department of Clinical Nutrition</orgName>
								<orgName type="institution">German Institute of Human Nutrition Potsdam-Rehbruecke</orgName>
								<address>
									<settlement>Nuthetal</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Jennifer</forename><surname>Kriebel</surname></persName>
							<affiliation key="aff4">
								<orgName type="department">German Center for Diabetes Research</orgName>
								<address>
									<settlement>Neuherberg</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff10">
								<orgName type="department">Institute of Epidemiology II</orgName>
								<orgName type="institution" key="instit1">Helmholtz Center Munich</orgName>
								<orgName type="institution" key="instit2">German Research Center for Environmental Health</orgName>
								<address>
									<settlement>Neuherberg</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff11">
								<orgName type="laboratory">Research Unit of Molecular Epidemiology</orgName>
								<orgName type="institution" key="instit1">Helmholtz Center Munich</orgName>
								<orgName type="institution" key="instit2">German Research Center for Environmental Health</orgName>
								<address>
									<settlement>Neuherberg</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Tonia</forename><surname>De Las Heras Gala</surname></persName>
							<affiliation key="aff10">
								<orgName type="department">Institute of Epidemiology II</orgName>
								<orgName type="institution" key="instit1">Helmholtz Center Munich</orgName>
								<orgName type="institution" key="instit2">German Research Center for Environmental Health</orgName>
								<address>
									<settlement>Neuherberg</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Anna</forename><surname>Malashicheva</surname></persName>
							<affiliation key="aff8">
								<orgName type="department">Institute of Molecular Biology and Genetics</orgName>
								<orgName type="institution">Almazov Federal Heart, Blood and Endocrinology Center; Saint-Petersburg</orgName>
								<address>
									<country key="RU">Russia</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Anna</forename><surname>Kostareva</surname></persName>
							<affiliation key="aff8">
								<orgName type="department">Institute of Molecular Biology and Genetics</orgName>
								<orgName type="institution">Almazov Federal Heart, Blood and Endocrinology Center; Saint-Petersburg</orgName>
								<address>
									<country key="RU">Russia</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Johan</forename><forename type="middle">F</forename><surname>Lock</surname></persName>
							<affiliation key="aff12">
								<orgName type="department">Department of General, Visceral, Vascular and Pediatric Surgery</orgName>
								<orgName type="institution">University Hospital of Wuerzburg</orgName>
								<address>
									<settlement>Wuerzburg</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Martin</forename><surname>Stockmann</surname></persName>
							<affiliation key="aff13">
								<orgName type="department">Department of General, Visceral and Transplantation Surgery</orgName>
								<orgName type="institution">Charit e University Medicine</orgName>
								<address>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Harald</forename><surname>Grallert</surname></persName>
							<affiliation key="aff4">
								<orgName type="department">German Center for Diabetes Research</orgName>
								<address>
									<settlement>Neuherberg</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff9">
								<orgName type="institution">Institute of Molecular Biotechnology GmbH</orgName>
								<address>
									<settlement>Vienna</settlement>
									<country key="AT">Austria</country>
								</address>
							</affiliation>
							<affiliation key="aff10">
								<orgName type="department">Institute of Epidemiology II</orgName>
								<orgName type="institution" key="instit1">Helmholtz Center Munich</orgName>
								<orgName type="institution" key="instit2">German Research Center for Environmental Health</orgName>
								<address>
									<settlement>Neuherberg</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Norbert</forename><surname>Gretz</surname></persName>
							<affiliation key="aff7">
								<orgName type="department" key="dep1">Center for Medical Research</orgName>
								<orgName type="department" key="dep2">Faculty of Medicine Mannheim at</orgName>
								<orgName type="institution">Heidelberg University</orgName>
								<address>
									<settlement>Mannheim</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Steven</forename><surname>Dooley</surname></persName>
							<affiliation key="aff5">
								<orgName type="department" key="dep1">Molecular Hepatology -Alcohol Associated Diseases</orgName>
								<orgName type="department" key="dep2">Faculty of Medicine Mannheim at</orgName>
								<orgName type="institution" key="instit1">Medical Clinic II</orgName>
								<orgName type="institution" key="instit2">Heidelberg University</orgName>
								<address>
									<settlement>Mannheim</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Andreas</forename><forename type="middle">Fh</forename><surname>Pfeiffer</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Department of Clinical Nutrition</orgName>
								<orgName type="institution">German Institute of Human Nutrition Potsdam-Rehbruecke</orgName>
								<address>
									<settlement>Nuthetal</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff1">
								<orgName type="department">Department of Endocrinology, Diabetes and Nutrition</orgName>
								<orgName type="institution">Charit e University Medicine</orgName>
								<address>
									<addrLine>Campus Benjamin Franklin</addrLine>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff4">
								<orgName type="department">German Center for Diabetes Research</orgName>
								<address>
									<settlement>Neuherberg</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Natalia</forename><surname>Rudovich</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Department of Clinical Nutrition</orgName>
								<orgName type="institution">German Institute of Human Nutrition Potsdam-Rehbruecke</orgName>
								<address>
									<settlement>Nuthetal</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff1">
								<orgName type="department">Department of Endocrinology, Diabetes and Nutrition</orgName>
								<orgName type="institution">Charit e University Medicine</orgName>
								<address>
									<addrLine>Campus Benjamin Franklin</addrLine>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main">Modulation of insulin degrading enzyme activity and liver cell proliferation</title>
					</analytic>
					<monogr>
						<imprint>
							<date/>
						</imprint>
					</monogr>
					<idno type="MD5">867B6F723FC0D2904AFA4DAAE71F0E22</idno>
					<idno type="DOI">10.1080/15384101.2015.1046647</idno>
					<note type="submission">Submitted: 01/05/2015; Revised: 04/23/2015; Accepted: 04/24/2015</note>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.7.2-SNAPSHOT" ident="GROBID" when="2022-05-18T11:38+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<textClass>
				<keywords>
					<term>hepatocellular carcinoma, insulin-degrading enzyme, non-alcoholic fatty liver disease, proliferation, type 2 diabetes mellitus Abbreviations: CCNG2, Cyclin G2 gene, CDKN1A/P21, Cyclin-dependent kinase inhibitor 1A (p21, Cip1) gene</term>
					<term>CDKN1B/P27, Cyclin-dependent kinase inhibitor 1B (p27, Kip1) gene</term>
					<term>FAS, Fas cell surface death receptor gene</term>
					<term>FBS, Fetal bovine serum</term>
					<term>IDE, Insulin-degrading enzyme</term>
					<term>MCM2, Minichromosome maintenance complex component 2 gene</term>
					<term>MKI67, Marker of proliferation Ki-67 gene</term>
					<term>NAS, Non-alcoholic fatty liver disease score</term>
					<term>NAFLD, Non-alcoholic fatty liver disease</term>
					<term>OGTT, Oral glucose tolerance test</term>
					<term>PCNA, Proliferating cell nuclear antigen gene</term>
					<term>qRT-PCR, Quantitative real-time PCR</term>
					<term>SESN1, Sestrin 1 gene</term>
					<term>TP53, Tumor protein p53 gene</term>
					<term>TP53I3, Tumor protein p53 inducible protein 3 gene</term>
					<term>T2DM, Type 2 diabetes mellitus</term>
				</keywords>
			</textClass>
			<abstract>
<div xmlns="http://www.tei-c.org/ns/1.0"><p><s>Diabetes mellitus type 2 (T2DM), insulin therapy, and hyperinsulinemia are independent risk factors of liver cancer.</s><s>Recently, the use of a novel inhibitor of insulin degrading enzyme (IDE) was proposed as a new therapeutic strategy in T2DM.</s><s>However, IDE inhibition might stimulate liver cell proliferation via increased intracellular insulin concentration.</s><s>The aim of this study was to characterize effects of inhibition of IDE activity in HepG2 hepatoma cells and to analyze liver specific expression of IDE in subjects with T2DM.</s><s>HepG2 cells were treated with 10 nM insulin for 24 h with or without inhibition of IDE activity using IDE RNAi, and cell transcriptome and proliferation rate were analyzed.</s><s>Human liver samples (n D 22) were used for the gene expression profiling by microarrays.</s><s>In HepG2 cells, IDE knockdown changed expression of genes involved in cell cycle and apoptosis pathways.</s><s>Proliferation rate was lower in IDE knockdown cells than in controls.</s><s>Microarray analysis revealed the decrease of hepatic IDE expression in subjects with T2DM accompanied by the downregulation of the p53-dependent genes FAS and CCNG2, but not by the upregulation of proliferation markers MKI67, MCM2 and PCNA.</s><s>Similar results were found in the liver microarray dataset from GEO Profiles database.</s><s>In conclusion, IDE expression is decreased in liver of subjects with T2DM which is accompanied by the dysregulation of p53 pathway.</s><s>Prolonged use of IDE inhibitors for T2DM treatment should be carefully tested in animal studies regarding its potential effect on hepatic tumorigenesis.</s></p></div>
			</abstract>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Introduction</head><p><s>Insulin degrading enzyme (IDE) is a major enzyme responsible for insulin degradation in the liver.</s><s>Animal models and genetic association studies in humans suggest that IDE is an important player in the pathogenesis of type 2 diabetes (T2DM). <ref type="bibr" target="#b0">1,</ref><ref type="bibr" target="#b2">2</ref></s><s>Recently, Maianti et al. <ref type="bibr" target="#b4">3</ref> proposed the use of an IDE inhibitor, 6bK, as a new therapeutic strategy to treat T2DM.</s><s>This conclusion was based on the 6bK mediated decrease of postprandial glucose concentrations after oral glucose administration (OGTT) in lean and obese mice.</s><s>Whether inhibition of IDE activity is also efficient as an antidiabetic strategy in humans still remains to be established, and several opposite findings need to be taken into account.</s></p><p><s>In particular, the inhibition of IDE activity results in increased extracellular and intracellular insulin concentration <ref type="bibr" target="#b6">4</ref> which might be crucial for insulin-dependent regulation of gene expression and cell proliferation.</s><s>T2DM is an independent risk factor of hepatocellular carcinoma (HCC) <ref type="bibr" target="#b8">5</ref> possibly because of chronic hyperinsulinemia.</s><s>A non-alcoholic fatty liver disease (NAFLD) frequently associated with insulin resistance and hyperinsulinemia <ref type="bibr" target="#b9">6</ref> was also shown to be a HCC risk factor. <ref type="bibr" target="#b10">7</ref></s><s>Moreover, some antidiabetic treatments such as insulin and insulin secretagogues, sulfonylureas and glinides, increased the risk for overall cancer probably via the same mechanism. <ref type="bibr" target="#b11">8</ref></s><s>herefore, modulating IDE activity may represent a key link between T2DM and liver cancer.</s><s>To evaluate the effects of IDE inhibition in vitro, we here characterized the effects of IDE knockdown on the transcriptome and proliferation rate of HepG2 hepatoma cells.</s><s>To study the IDE regulation in humans, we additionally analyzed the IDE expression and its association with the expression of proliferation and p53related markers in liver samples of subjects with and without T2DM.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Results</head><p><s>Effects of IDE knockdown on the HepG2 cell transcriptome Insulin increased the proliferation (Fig. <ref type="figure" target="#fig_0">1A</ref>) as well as the mRNA expression of proliferative markers MKI67, MCM2 and PCNA (Figs.</s><s><ref type="figure" target="#fig_0">1B-D</ref>) in HepG2 cells.</s><s>To study effects of the inhibition of IDE activity in vitro, HepG2 cells were transfected with siRNA for IDE (IDE RNAi) or control siRNA (Ctrl RNAi) and treated with vehicle or 10 nM insulin for 24 h.</s></p><p><s>IDE knockdown resulted in a significant IDE reduction on the mRNA and protein level (Fig. <ref type="figure" target="#fig_1">2A</ref>).</s><s>Insulin treatment induced alterations of only 3 genes in cells transfected with non-targeting control siRNA, and all of them were lower than 1.3-fold (Table <ref type="table" target="#tab_0">S1</ref>).</s><s>However, in cells with IDE knockdown, insulin cause expression changes of 249 genes, and 19 of them were greater than 1.3-fold (Table <ref type="table" target="#tab_0">S1</ref>).</s><s>Pathway analysis revealed the single pathway regulated in these conditions, the cell cycle pathway, involved CDC6, GINS4, CDC20, and CENPI genes.</s><s>Furthermore, we analyzed transcriptomic changes in HepG2 hepatoma cells upon IDE knockdown.</s><s>DAVID analysis revealed that induction of apoptosis (Fig. <ref type="figure" target="#fig_1">2B</ref>) and p53 pathway (not shown) are one of most biological processes and signaling pathways, respectively, altered upon IDE knockdown.</s><s>Interestingly, the expression of p53-dependent pro-apoptotic genes FAS and CCNG2 was decreased, whereas TP53I3 and SESN1 increased upon IDE RNAi which was confirmed by qRT-PCR (Fig. <ref type="figure" target="#fig_1">2C</ref>).</s><s>We additionally measured expression of the TP53 gene and the expression of 2 prognostic markers for NASH-related HCC, 9,10 p21 and p27, by qRT-PCR and found no significant alterations (data not shown).</s><s>Proliferation markers MKI67, MCM2 and PCNA were up-regulated in IDE knockdown cells (Fig. <ref type="figure" target="#fig_1">2D</ref>).</s><s>Moreover, pAkt phosphorylation was slightly increased and expression of insulin-targeted gluconeogenesis genes G6PC and PEPCK decreased upon inhibition of IDE activity (Fig. <ref type="figure" target="#fig_0">S1</ref>) which points out the activation of Akt signaling pathway.</s><s>Nevertheless, in serum-supplemented medium, the proliferation rate was lower in IDE knockdown cells in comparison to cells transfected with control siRNA (Fig. <ref type="figure" target="#fig_1">2E</ref>).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>IDE expression in liver cancer cells lines with different proliferative capacity</head><p><s>To analyze possible association between IDE expression level and cell proliferation, we measured mRNA expression of IDE gene in liver cancer cells lines with different proliferative capacity (HepG2, HCC-M, HCC-T, Hep3B, HLF, PLC, FLC4, HLE and Huh7).</s><s>The IDE expression in studied HCC cell lines was expressed as the n-fold difference relative to HepG2 samples.</s><s>We could identify 2 groups of HCC cell lines, one with high IDE expression which included Huh7 and HCC-T cells, and another with relatively low levels of IDE mRNA including HepG2, HCC-M, Hep3B, HLF, PLC, FLC4 and HLE cells (Fig. <ref type="figure" target="#fig_1">S2</ref>).</s><s>No correlation of IDE expression with proliferation markers MKI67 and cyclin B2 or tumor suppressor gene E-cadherin were found (data not shown).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>IDE expression in the liver of subjects with T2DM</head><p><s>Because the published data about the IDE activity in subjects with T2DM are controversial, we further analyzed the IDE expression in liver samples from 3 groups of patients -NAFLD with T2DM, NAFLD without T2DM, and metabolically healthy subjects without NAFLD or T2DM (Table <ref type="table" target="#tab_0">1</ref>).</s><s>For this, gene expression profiling of liver samples was performed using Illumina microarrays.</s><s>In diabetic subjects with NAFLD, liver IDE expression was decreased in comparison with non-diabetic subjects with NAFLD (p D 6£10 ¡5 , after multiple testing correction p D 0.0044) or metabolic healthy subjects (p D 0.0027, after multiple testing correction p D 0.0357) (Table <ref type="table" target="#tab_1">2</ref>).</s><s>This was accompanied by the decrease of TP53 expression, as well as expression of p53-target genes FAS, TP53I3, and SESN1 (Table <ref type="table" target="#tab_1">2</ref>).</s><s>Unexpectedly, the expression of HCC markers p21 and p27, as well as of proliferation marker PCNA was also downregulated in subjects with T2DM.</s><s>No expression differences of indicated genes between non-diabetic subjects with NAFLD and metabolically healthy subjects were found (Table <ref type="table" target="#tab_1">2</ref>).</s></p><p><s>Interestingly, IDE expression strongly and positively correlated with expression levels all abovementioned proliferation markers (r D 0.580, p D 0.005 for MKI67; r D 0.643, p D 0.001 for MCM2; r D 0.706, p &lt; 0.001 for PCNA), p53associated genes (r D 0.880 for FAS, r D 0.886 for CCNG2, r D 0.863 for TP53I3, r D 0.835 for SESN1, r D 0.868 for TP53, p &lt; 0.001 for all genes), and HCC markers (r D 0.709, p &lt; 0.001 and r D 0.825, p &lt; 0.001 for p21 and p27, respectively).</s><s>No association of expression of hepatic IDE or other markers with fasting insulin levels were found (Table <ref type="table">S3</ref>).</s><s>IDE expression levels also did not correlate with NAFLD activity score and liver fibrosis (Table <ref type="table">S3</ref>).</s></p><p><s>Moreover, we analyzed 2 presently public available liver microarray data sets from patients with T2DM using the GEO Profiles database.</s><s>In the first dataset <ref type="bibr" target="#b16">11</ref> (GSE15653), we found the decrease of liver-specific IDE expression in obese patients with T2DM compared to lean non-diabetic subjects accompanied by the decrease of MKI67, FAS, CCNG2, and SESN1 expression, as well as by the increase of p21 expression (Table <ref type="table">S4</ref>).</s><s>Obese subjects without T2DM showed similar trends of hepatic gene expression (Table <ref type="table">S4</ref>).</s><s>IDE expression levels correlated with FAS (r D 0.509, p D 0.031), CCNG2 (r D 0.674, p D 0.002), TP53I3 (r D ¡0.472, p D 0.048), p21 (r D ¡0.657, p D 0.003), and p27 (r D 0.709, p D 0.001) expression.</s><s>In the second data set <ref type="bibr" target="#b17">12</ref> (GSE23343), no difference of liver-specific IDE expression was found between subjects with and without T2DM (data not shown).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Discussion</head><p><s>Our investigation indicates the decrease of IDE expression in the liver of subjects with T2DM.</s><s>Indeed, in diabetic subjects with NAFLD, liver IDE expression was decreased in comparison with non-diabetic subjects with NAFLD or metabolic healthy subjects.</s><s>Moreover, in one of 2 analyzed GEO datasets, we found the decrease of liver-specific IDE expression in obese patients with T2DM compared to lean non-diabetic subjects.</s><s>Interestingly, obese subjects without T2DM showed similar trends of hepatic IDE expression suggesting that the decrease of IDE activity could be the primarily defect in some metabolic diseases.</s></p><p><s>Indeed, decreased hepatic insulin degradation is an early marker of a disturbed insulin metabolism, <ref type="bibr" target="#b18">13,</ref><ref type="bibr" target="#b19">14</ref> and some polymorphisms of the IDE gene are associated with reduced insulin clearance and diabetes susceptibility. <ref type="bibr" target="#b2">2</ref></s><s>Chronically exposed hyperinsulinemia increases insulin resistance and impairs insulin secretion. <ref type="bibr" target="#b2">2</ref></s><s>Decreased IDE activity was described in adipocytes from subjects with diabetes. <ref type="bibr" target="#b20">15</ref></s><s>Moreover, hyperglycemia abolishes an insulin-induced increase of IDE activity. <ref type="bibr" target="#b22">16</ref></s><s>Obviously, the treatment of diabetic subjects with IDE inhibitors will not have a beneficial impact, if such treatment will be at all tolerable.</s></p><p><s>Furthermore, our in vitro data suggest that IDE knockdown dysregulates expression of genes involved in the cell cycle and apoptosis induction.</s><s>Obviously, the IDE inhibition in vitro led to the amplification of the insulin-induced effects which are quickly switched off in intact cells because of prompt insulin degradation.</s><s>It can explain why only 3 genes were changed in control cells 24h after the insulin stimulation, whereas 249 genes were regulated in IDE knockdown cells.</s><s>Furthermore, proliferation markers MKI67, MCM2 and PCNA were significantly upregulated in IDE knockdown cells.</s><s>The up-regulation of proliferation induced by IDE inhibition was demonstrated in skeletal myoblasts. <ref type="bibr" target="#b23">17</ref></s><s>nexpectedly, in HepG2 cells, we detected the decrease of cell proliferation upon IDE knockdown.</s><s>No correlation between expression of IDE and proliferative markers was found in liver cancer cells lines with different proliferative capacity.</s><s>In human liver samples, the decrease of IDE expression was not accompanied by the upregulation of proliferation markers.</s><s>Moreover, the IDE expression in human liver positively correlated with expression levels of MKI67, PCNA, and MCM2.</s><s>Thus, the decrease of IDE expression in vivo is not accompanied by the increase of the cell proliferation.</s><s>A number of unknown molecular mechanisms might contribute to this effect.</s></p><p><s>Particularly, we found that the IDE knockdown in HepG2 cells led to the dysregulation of p53 pathway.</s><s>Indeed, the expression of some p53-dependent pro-apoptotic genes, FAS and CCNG2, was decreased, whereas the expression of other p53dependent genes, TP53I3 and SESN1, was increased upon IDE RNAi.</s><s>Analysis of microarray data sets confirmed that the decrease of IDE expression was accompanied by the downregulation of FAS and CCNG2 genes, and their expression levels positively correlated with IDE expression.</s><s>Interestingly, the hepatic expression of p53-dependent HCC marker p21 was upregulated in T2DM subjects in one of analyzed liver studies and downregulated in another study.</s><s>Previously published data received from human brain samples confirm our finding about the link between the IDE and p53 pathway.</s><s>In sporadic Alzheimer's disease, decrease of IDE expression was accompanied by the enhanced p53 expression. <ref type="bibr" target="#b24">18</ref></s><s>ther side effects of IDE inhibition should be mentioned.</s><s>IDE degrades a variety of metabolically active substrates, including glucagon, amylin, IGF-1, ANP etc. <ref type="bibr" target="#b4">3</ref> The IDE substrate degradation is hypothesized to occur at rates that depend on their relative concentrations during secretory bursts. <ref type="bibr" target="#b4">3</ref></s><s>Consistent with this hypothesis, the acute IDE inhibition improved glucose tolerance after OGTT in mice <ref type="bibr" target="#b4">3</ref> because of a proportionally larger insulin release as compared to glucagon.</s><s>However, in T2DM subjects, the glucagon level is increased and an "incretin effect" on insulin secretion is abolished.</s><s>Thus, the IDE inhibition in case of such insulinto-glucagon imbalance may result in slower degradation of glucagon, and in this way intensify glucose intolerance via increase of postprandial gluconeogenesis. <ref type="bibr" target="#b4">3</ref></s><s>oreover, IDE inhibition may lead to amyloid deposition and cytotoxicity in pancreatic b-cells <ref type="bibr" target="#b25">19</ref> and dysregulate other cellular processes such as proteosomal degradation. <ref type="bibr" target="#b26">20</ref></s><s>Therefore, effects of prolonged treatment with IDE inhibitors should be necessarily tested in animal studies.</s><s>Notably, older IDE knockout mice exhibited a severe diabetic phenotype characterized by increased body weight and pronounced glucose and insulin intolerance which presents compensatory response to chronic hyperinsulinemia. <ref type="bibr" target="#b0">1</ref> In conclusion, our data suggest that IDE expression is decreased in liver of diabetic humans which is accompanied by the dysregulation of p53 pathway but not by the upregulation of proliferation markers.</s><s>Whether the treatment with IDE inhibitors can induce hepatocellular carcinoma should be elucidated in animal studies.</s><s>Moreover, IDE inhibition could intensify instead of improve glucose disturbances in T2DM.</s><s>Alternatively, enhanced degradation of insulin by an IDE activator, accompanied by insulin sensitization in peripheral tissues, may be a perspective strategy for T2DM treatment and needs further investigation.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Materials and Methods</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Cell culture</head><p><s>The human HCC cell lines (HepG2, HCC-M, HCC-T, Hep3B, HLF, PLC4, FLC4, HLE and Huh7) were grown in DMEM supplemented with 10% fetal bovine serum (FBS) (both from Life Technologies, Germany) and 1% penicillin/streptomycin (Sigma Aldrich, Germany).</s><s>Cells were incubated in a humidified atmosphere of 5% CO2 at 37 C.</s></p><p><s>To inhibit IDE activity in HepG2 cells, IDE silencing (RNAi) were used.</s><s>In preliminary experiments, we tested 4 predesigned FlexiTube IDE siRNAs from Qiagen (Hs_IDE_1, Hs_IDE_2, Hs_IDE_5, and Hs_IDE_6; more information is available at the QIAGEN's GeneGlobe Web portal).</s><s>Shortly, we attested silencing efficiency of 4 IDE siRNAs (separately and as a pool) to establish the best experimental set-up (Fig. <ref type="figure">S3</ref>).</s><s>In main experiments, cells (3£10 5 /well) were seeded on 6-well plates (TPP, Germany) covered with L-ornithine (Sigma Aldrich, Germany).</s><s>After 24h, cells were transfected with a pool of 2 siRNA for IDE (Hs_IDE_5 and Hs_IDE_6, 96 nM of each siRNA) or with an equivalent amount of AllStars Negative Control siRNA (Qiagen, Germany) in OptiMEM medium (Life Technologies, Germany) using 7.5 ml/well Lipofectamine 2000 (Life Technologies, Germany).</s><s>16 h after transfection, cells were treated with vehicle or 10 nM insulin (Sigma Aldrich, Germany) for 24 h in serum starvation condition.</s><s>All experiments were repeated 3 times.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Human liver study</head><p><s>We included 22 subjects from the cross-sectional INSIGHT (German Clinical Trials-Register: DRKS00005450) study who gave informed consent.</s><s>The study was conducted in accordance with the Declaration of Helsinki as reflected in a priori approval by the institution's human research committee.</s><s>Detailed medical history and physical examination data were obtained from all subjects.</s><s>Blood samples were obtained after overnight fasting and clinical chemistry was assessed using standard methods in certified Clinical Chemistry laboratories. <ref type="bibr" target="#b27">21</ref></s><s>T2DM was defined following the criteria of the American Diabetes Association. <ref type="bibr" target="#b29">22</ref></s><s>Liver specimens were taken from a non-pathologic liver segment during hepatic surgery.</s><s>Samples were flash-frozen in liquid nitrogen and stored at ¡80 C until RNA extraction procedure.</s><s>A part of the liver sample was used for histopathological analysis after fixing in 4% formalin (Histofix, Roth, Germany), embedding in paraffin, and staining with hematoxylin and eosin.</s><s>The unweighted sum of points for the intensity of liver steatosis, lobular inflammation and hepatocellular ballooning was used to calculate the NAS.</s><s>Exclusively healthy liver tissue was used for analyses, as a blinded clinical expert pathologist considered all harvested liver samples to be histologically normal with respect to pathologies except for NAFLD. <ref type="bibr" target="#b27">21</ref></s><s>For the gene expression profiling, subjects were categorized according to 3 groups -NAFLD with T2DM (n D 6), NAFLD without T2DM (n D 8), and metabolically healthy subjects without NAFLD and T2DM (n D 8).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Microarray analysis</head><p><s>Total RNA was purified using the RNeasy Mini Kit (Qiagen, Germany).</s><s>RNA quality was assessed by Agilent 2100 bioanalyzer using Agilent RNA 6000 Nano Kit (Agilent Technologies, Germany).</s><s>For HepG2 samples, biotinylated cRNA were prepared according to the standard Affymetrix protocol from 1 mg total RNA.</s><s>Fragmented cRNA was hybridized to GeneChip Human Gene 1.0 ST Arrays (Affymetrix, Germany) for 16h at 45 C. GeneChips were washed and stained in the Affymetrix Fluidics Station 450.</s><s>Microarrays were scanned with an Affymetrix scanner controlled by Affymetrix Microarray Suite software.</s></p><p><s>Human liver gene expression patterns were studied on the Illumina HumanHT-12 v4.0 BeadChip array. <ref type="bibr" target="#b30">23</ref></s><s>Sample preparation from human liver was performed as described at the Illumina Ò TotalPrep TM-96 RNA Amplification Kit (Revision Date: October 15, 2009) (Ambion, Darmstadt, Germany). <ref type="bibr" target="#b30">23</ref></s><s>antitative real-time PCR (qRT-PCR) Synthesis of cDNA was performed using the High Capacity cDNA Reverse Transcription Kit (Applied Biosystems, Germany).</s><s>QRT-PCR was carried out using Power SYBR Green PCR Master Mix and specific primers (Suppl.</s><s>Table <ref type="table" target="#tab_1">2</ref>) in ABI Prism 7700 sequence detection system (Applied Biosystems, Germany).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Western blotting</head><p><s>HepG2 protein extracts were prepared in the cell lysis buffer (Life Technologies, Germany).</s><s>Semi-dry immunoblots were performed with rabbit IDE antibody (1:1000, Hofheim, Germany), rabbit phospho-Akt (Ser473) antibody (1:1000, Life Technologies, Germany), rabbit b-actin antibody (1:2000, Sigma Aldrich, Germany), and anti-rabbit horseradish peroxidase-conjugated secondary antibody (1:2000, Life Technologies, Germany), and quantified using the CCD camera, Image Reader LAS-1000 Pro v 2.1 software (Fujifilm, Japan) and the AIDA Image Analyzer (Raytest, Germany).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Cell proliferation assay</head><p><s>HepG2 cells (5 £ 10 3 cells/well) were seeded into 96-well culture plates, grown for 24 h, and treated with various concentrations of insulin for 24 h.</s><s>In RNAi experiments, cells (8 £ 10 3 cells/well) were maintained in proliferation medium (DMEMC10% FBS), and the proliferation assay was performed 24h, 48h, 72h and 96 h after transfection.</s><s>For this, the CellTiter 96 Ò AQ ueous One Solution Cell Proliferation Assay (Promega, Germany) was used.</s><s>The absorbance was read at 490 nm using Wallac VICTOR2 1420 Multilabel plate reader.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Microarray processing and statistical analysis</head><p><s>For analysis of HepG2 microarray data, raw fluorescence intensity values were normalized applying quantile normalization, and gene expression values were converted to a log 2 scale.</s><s>CustomCDF Version 14 with Entrez based gene definitions was used for gene annotation.</s><s>Differences in gene expression were analyzed with JMG Genomics Version 6.0 from SAS (SAS Institute, Cary, NC, USA).</s><s>Genes with mean expression changes greater than 1.3 fold (log 2 greater than 0.3785 and lower than ¡0.3785) and which were significant after a false-discovery rate correction (p &lt; 0.05) were selected as regulated by experimental conditions and subjected for gene ontology (GO) and pathway analyses.</s><s>This was done with DAVID (Database for Annotation, Visualization, and Interpreted Discovery; http://david.abcc.</s><s>ncifcrf.gov/).</s><s>Microarray data were deposited in Gene Expression Omnibus database (accession no.</s><s>GSE61142).</s></p><p><s>For analysis of human liver microarray data, R software version 3.0.2</s><s>(2013-09-25) was used.</s><s>The data was log transformed and quantile normalization was performed.</s><s>Significance testing was performed using the Bioconductor-package limma. <ref type="bibr" target="#b31">24</ref></s><s>All models were adjusted for sex, age and BMI.</s><s>The significance level was adjusted according to Benjamini-Hochberg. <ref type="bibr" target="#b32">25</ref></s><s>For correlation analysis, Spearman's rank correlation coefficient was used.</s></p><p><s>Analysis of public available microarray datasets from the GEO Profiles database (http://www.ncbi.nlm.nih.gov/geoprofiles/) was provided as described. <ref type="bibr" target="#b33">26</ref></s><s>In the first data set (GSE15653), surgical liver biopsies from 13 obese (9 with T2DM) and 5 control subjects were studied. <ref type="bibr" target="#b16">11</ref></s><s>In the second dataset (GSE23343), percutaneous needle liver biopsies from 10 people with T2DM and 7 normal subjects were analyzed. <ref type="bibr" target="#b17">12</ref></s><s>If multiple probe sets were associated with the same gene, the probe with a maximum estimated fold change was used for analysis.</s></p><p><s>In vitro data were analyzed using 2-tailed Student's t-test or repeated measurement ANOVA (RM ANOVA), and p-value &lt; 0.05 was considered as statistically significant.</s><s>Statistical analyses were performed with SPSS 20.0 (Chicago, USA).</s><s>All values are expressed as means § SD.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Disclosure of Potential Conflicts of Interest</head><p><s>No potential conflicts of interest were disclosed.</s></p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><head>Figure 1 .</head><label>1</label><figDesc><div><p><s>Figure 1.</s><s>Insulin increases proliferation of HepG2 cells.</s><s>(A) Concentration-dependent effects of insulin on the HepG2 proliferation.</s><s>Cells were treated with vehicle or various concentration of insulin for 24 h.</s><s>Cell proliferation was measured using CellTiter 96 Ò AQ ueous One Solution Cell Proliferation Assay.</s><s>(B-D) HepG2 cells were treated with vehicle (white bars), 1 nM insulin (striped bars) or 10 nM insulin (black bars) for 8h, 16h or 24 h.</s><s>Expression of mRNA of proliferative markers MKI67 (B), MCM2 (C), and PCNA (D) was measured using qRT-PCR and normalized to the expression of the housekeeper gene HPRT1.</s><s>Data: mean § SD; *P &lt; 0.05, **p &lt; 0.01 vs. vehicle in 2-tail Student's t-test.</s></p></div></figDesc><graphic coords="2,53.27,353.57,336.14,286.22" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_1"><head>Figure 2 .</head><label>2</label><figDesc><div><p><s>Figure 2. Effects of the IDE knockdown on proliferative and apoptotic markers in HepG2 cells.</s><s>HepG2 cells were transfected with siRNA for IDE or AllStars Negative Control siRNA (Ctrl RNAi) and treated with vehicle (white bars) or 10 nM insulin (black bars) for 24 h.</s><s>(A) Expression of IDE mRNA and protein.</s><s>Representative western blots for IDE and b-actin are shown.</s><s>(B) Selected annotation of affected biological processes (control RNAi vs. IDE RNAi) performed using DAVID database.</s><s>Full classification is shown in Table S2.</s><s>(C) qRT-PCR validation of microarray data for genes of p53 pathway.</s><s>Target gene expression was normalized to the expression of the housekeeper gene HPRT1.</s><s>(D) mRNA expression of proliferative markers MKI67, MCM2 and PCNA.</s><s>*P &lt; 0.05 for IDE RNAi vs. Ctrl RNAi in vehicle-(white bars) or insulin-treated (black bars) cells, respectively, in 2-tail Student's t-test.</s><s>(E) Proliferation of Ctrl RNAi and IDE RNAi transfected HepG2 cells in proliferation medium (DMEM C 10% FBS) measured using CellTiter 96 Ò AQ ueous One Solution Cell Proliferation Assay.</s><s>Absorbance values (490 nm) are shown.</s><s>P D 0.007 for time effect, p D 0.037 for siRNA effect, and p D 0.198 for time*siRNA in RM ANOVA.</s><s>*P &lt; 0.05 vs. control RNAi in 2-tail Student's t-test.</s><s>Data: mean § SD.</s></p></div></figDesc><graphic coords="3,77.51,72.65,456.14,451.10" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_0"><head>Table 1 .</head><label>1</label><figDesc><div><p><s>Clinical characteristics of study subjects</s></p></div></figDesc><table><row><cell></cell><cell></cell><cell>Subcohort I</cell><cell></cell><cell></cell><cell cols="2">Subcohort II</cell><cell></cell><cell></cell></row><row><cell></cell><cell>NAFLD/no</cell><cell>No NAFLD/no</cell><cell></cell><cell>NAFLD C</cell><cell>NAFLD/no</cell><cell>No NAFLD/no</cell><cell></cell><cell></cell></row><row><cell></cell><cell>T2DM</cell><cell>T2DM</cell><cell>P-value</cell><cell>T2DM</cell><cell>T2DM</cell><cell>T2DM</cell><cell>P-value *</cell><cell>P-value **</cell></row><row><cell>n (male) (n)</cell><cell>8 (3)</cell><cell>8 (5)</cell><cell>NS</cell><cell>6 (2)</cell><cell>6 (2)</cell><cell>6 (4)</cell><cell>NS</cell><cell>NS</cell></row><row><cell>Age (years)</cell><cell>57  § 5</cell><cell>4 9 § 5</cell><cell>N S</cell><cell>6 7  § 4</cell><cell>5 4  § 6</cell><cell>4 4  § 6</cell><cell>NS</cell><cell>0.015</cell></row><row><cell>BMI (kg/m 2 )</cell><cell>30.5  § 3.7</cell><cell>24.6  § 1.4</cell><cell>NS</cell><cell>29.9  § 1.7</cell><cell>31.5  § 4.8</cell><cell>24.3  § 1.8</cell><cell>NS</cell><cell>0.041</cell></row><row><cell>HbA1c (%)</cell><cell>5.43  § 0.15</cell><cell>5.61  § 0.20</cell><cell>NS</cell><cell>6.25  § 0.24</cell><cell>5.52  § 0.12</cell><cell>5.38  § 0.17</cell><cell>0.009</cell><cell>0.017</cell></row><row><cell>Histological liver steatosis (%)</cell><cell>38.75  § 8.11</cell><cell>1.25  § 1.25</cell><cell>&lt;0.001</cell><cell>26.67  § 10.54</cell><cell>38.33  § 11.08</cell><cell>1.67  § 1.66</cell><cell>NS</cell><cell>0.026</cell></row></table><note><p><s>Subjects were paired according to clinical parameters of NAFLD/no T2DM group (subcohort I) or NAFLD C T2DM group (subcohort II) for the following microarray data analysis.</s><s>*-NAFLD/no T2DM vs. NAFLD C T2DM. **-no NAFLD/no T2DM vs. NAFLD C T2DM.</s><s>NSnot significant (p &gt; 0.05).</s><s>Data: mean § SD.</s></p></note></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_1"><head>Table 2 .</head><label>2</label><figDesc><div><p><s>Gene expression in liver of subjects with and without T2DM</s></p></div></figDesc><table><row><cell></cell><cell>adj. p-value</cell><cell>0.9838</cell><cell>0.9849</cell><cell>0.9838</cell><cell>0.9838</cell><cell>0.9838</cell><cell>0.9838</cell><cell>0.9838</cell><cell>0.9838</cell><cell>0.9838</cell><cell>0.9838</cell><cell>0.9838</cell><cell></cell></row><row><cell>NAFLD/no T2DM vs. no NAFLD/no T2DM</cell><cell>log2 FC p-value</cell><cell>0.48 0.1423</cell><cell>0.03 0.7601</cell><cell>0.56 0.0404</cell><cell>0.55 0.2713</cell><cell>0.72 0.0737</cell><cell>0.21 0.5864</cell><cell>0.42 0.1980</cell><cell>0.63 0.1348</cell><cell>0.29 0.2089</cell><cell>0.36 0.5563</cell><cell>0.37 0.4105</cell><cell></cell></row><row><cell>NAFLD/no T2DM vs. NAFLDCT2DM</cell><cell>log2 FC p-value adj. p-value</cell><cell>1.61 &lt;0.0001 0.0044</cell><cell>0.17 0.1284 0.1968</cell><cell>0.46 0.1272 0.1955</cell><cell>2.17 0.0004 0.0046</cell><cell>1.77 0.0003 0.0045</cell><cell>0.86 0.0525 0.1024</cell><cell>0.78 0.0346 0.0754</cell><cell>1.65 0.0009 0.0065</cell><cell>1.29 &lt;0.0001 0.0044</cell><cell>1.78 0.0130 0.0370</cell><cell>1.64 0.0022 0.0108</cell><cell></cell></row><row><cell>NAFLDCT2DM vs. no NAFLD/no T2DM</cell><cell>p-value adj. p-value Gene symbol Probe ID log2 FC</cell><cell>0.0027 0.0357 IDE ILMN_1769883 ¡1.14</cell><cell>0.2079 0.3293 MKI67 ILMN_1734827 ¡0.14</cell><cell>0.7353 0.7947 MCM2 ILMN_1681503 0.10</cell><cell>0.0058 0.0416 PCNA ILMN_1694177 ¡1.62</cell><cell>0.0226 0.0818 FAS ILMN_2319077 ¡1.04</cell><cell>0.1386 0.2532 CCNG2 ILMN_2228732 ¡0.65</cell><cell>0.3133 0.4326 TP53I3 ILMN_2358919 ¡0.36</cell><cell>0.0313 0.0998 SESN1 ILMN_1800626 ¡1.02</cell><cell>0.0004 0.0357 TP53 ILMN_1779356 ¡0.99</cell><cell>0.0443 0.1236 CDKN1A/P21 ILMN_1784602 ¡1.42</cell><cell>0.0150 0.0646 CDKN1B/P27 ILMN_1722811 ¡1.27</cell><cell>All models were adjusted for sex, age and BMI. Log2 FC</cell></row></table><note><p><s>-log2 of fold change, adj.</s><s>p-value -p-value corrected for multiple testing.</s></p></note></figure>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot">www.tandfonline.com</note>
		</body>
		<back>
			<div type="annex">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Funding</head><p><s>The study was supported by a grant from German Diabetic Association (Allgemeine Projektf€ orderung der DDG 2011, OP and NR; Allgemeine Projektf€ orderung der DDG 2012, CvL and SD€ o) and from German Ministry of Education and Science (BMBF, ROS10-058 GERUSSFIT, A.P. and N.R.).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Supplemental Material</head><p><s>Supplemental data for this article can be accessed on the publisher's website.</s></p></div>			</div>
			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title level="a" type="main">Deletion of insulin-degrading enzyme elicits antipodal, age-dependent effects on glucose and insulin tolerance</title>
		<author>
			<persName><forename type="first">Abdul-Hay</forename><surname>So</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Kang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Mcbride</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Zhao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Leissring</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">PloS one</title>
		<imprint>
			<biblScope unit="volume">6</biblScope>
			<date type="published" when="2011">2011. e20818</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b1">
	<monogr>
		<title/>
		<idno type="DOI">10.1371/journal.pone.0020818</idno>
		<idno type="PMID">21695259</idno>
		<ptr target="http://dx.doi.org/10.1371/journal.pone.0020818" />
		<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title level="a" type="main">Polymorphisms within insulin-degrading enzyme (IDE) gene determine insulin metabolism and risk of type 2 diabetes</title>
		<author>
			<persName><forename type="first">N</forename><surname>Rudovich</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><surname>Pivovarova</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Fisher</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Fischer-Rosinsky</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Spranger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Mohlig</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">B</forename><surname>Schulze</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Boeing</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">F</forename><surname>Pfeiffer</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Mol Med</title>
		<imprint>
			<biblScope unit="volume">87</biblScope>
			<biblScope unit="page" from="1145" to="1151" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b3">
	<monogr>
		<title/>
		<idno type="DOI">10.1007/s00109-009-0540-6</idno>
		<idno type="PMID">19809796</idno>
		<ptr target="http://dx.doi.org/10.1007/s00109-009-0540-6" />
		<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title level="a" type="main">Anti-diabetic activity of insulin-degrading enzyme inhibitors mediated by multiple hormones</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">P</forename><surname>Maianti</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Mcfedries</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><forename type="middle">H</forename><surname>Foda</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">E</forename><surname>Kleiner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><forename type="middle">Q</forename><surname>Du</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Leissring</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">J</forename><surname>Tang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Charron</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Seeliger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Saghatelian</surname></persName>
		</author>
		<idno type="PMID">24847884</idno>
	</analytic>
	<monogr>
		<title level="j">Nature</title>
		<imprint>
			<biblScope unit="volume">511</biblScope>
			<biblScope unit="page" from="94" to="98" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b5">
	<monogr>
		<title/>
		<idno type="DOI">10.1038/nature13297</idno>
		<ptr target="http://dx.doi.org/10.1038/nature13297" />
		<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title level="a" type="main">Designed inhibitors of insulin-degrading enzyme regulate the catabolism and activity of insulin</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Leissring</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Malito</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Hedouin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Reinstatler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Sahara</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Abdul-Hay</forename><surname>So</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Choudhry</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">M</forename><surname>Maharvi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">H</forename><surname>Fauq</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Huzarska</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">PloS one</title>
		<imprint>
			<biblScope unit="volume">5</biblScope>
			<biblScope unit="page">e10504</biblScope>
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b7">
	<monogr>
		<title/>
		<idno type="DOI">10.1371/journal.pone.0010504</idno>
		<idno type="PMID">20498699</idno>
		<ptr target="http://dx.doi.org/10.1371/journal.pone.0010504" />
		<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title level="a" type="main">Non-viral causes of hepatocellular carcinoma</title>
		<author>
			<persName><forename type="first">W</forename><surname>Blonski</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">S</forename><surname>Kotlyar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">A</forename><surname>Forde</surname></persName>
		</author>
		<idno type="DOI">10.3748/wjg.v16.i29.3603</idno>
		<idno type="PMID">20677332</idno>
		<ptr target="http://dx.doi.org/10.3748/wjg.v16.i29.3603" />
	</analytic>
	<monogr>
		<title level="j">World J Gastroenterol</title>
		<imprint>
			<biblScope unit="volume">16</biblScope>
			<biblScope unit="page" from="3603" to="3615" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title level="a" type="main">Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: Selected practical issues in their evaluation and management</title>
		<author>
			<persName><forename type="first">R</forename><surname>Vuppalanchi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Chalasani</surname></persName>
		</author>
		<idno type="DOI">10.1002/hep.22603</idno>
		<idno type="PMID">19065650</idno>
		<ptr target="http://dx.doi.org/10.1002/hep.22603" />
	</analytic>
	<monogr>
		<title level="j">Hepatology</title>
		<imprint>
			<biblScope unit="volume">49</biblScope>
			<biblScope unit="page" from="306" to="317" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title/>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">A</forename><surname>Michelotti</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">V</forename><surname>Machado</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">M</forename><surname>Diehl</surname></persName>
		</author>
		<author>
			<persName><surname>Nafld</surname></persName>
		</author>
		<author>
			<persName><surname>Cancer</surname></persName>
		</author>
		<idno type="DOI">10.1038/nrgastro.2013.183</idno>
		<idno type="PMID">24080776</idno>
		<ptr target="http://dx.doi.org/10.1038/nrgastro.2013.183" />
	</analytic>
	<monogr>
		<title level="j">Nat Rev Gastroenterol Hepatol</title>
		<imprint>
			<biblScope unit="volume">10</biblScope>
			<biblScope unit="page" from="656" to="665" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b11">
	<analytic>
		<title level="a" type="main">Oral insulin secretagogues, insulin, and cancer risk in type 2 diabetes mellitus</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">H</forename><surname>Chang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">W</forename><surname>Lin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">C</forename><surname>Wu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">S</forename><surname>Lai</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">M</forename><surname>Chuang</surname></persName>
		</author>
		<idno type="DOI">10.1210/jc.2012-1162</idno>
		<idno type="PMID">22563104</idno>
		<ptr target="http://dx.doi.org/10.1210/jc.2012-1162" />
	</analytic>
	<monogr>
		<title level="j">J Clin Endocrinol Metab</title>
		<imprint>
			<biblScope unit="volume">97</biblScope>
			<biblScope unit="page" from="E1170" to="1175" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b12">
	<analytic>
		<title level="a" type="main">CDKN1A: a double-edged sword in fatty liver?</title>
		<author>
			<persName><forename type="first">L</forename><surname>Valenti</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Dongiovanni</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cell cycle</title>
		<imprint>
			<biblScope unit="volume">13</biblScope>
			<biblScope unit="page" from="1371" to="1372" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b13">
	<monogr>
		<title/>
		<idno type="DOI">10.4161/cc.28754</idno>
		<idno type="PMID">24699009</idno>
		<ptr target="http://dx.doi.org/10.4161/cc.28754" />
		<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b14">
	<analytic>
		<title level="a" type="main">p27 Is a critical prognostic biomarker in non-alcoholic steatohepatitis-related hepatocellular carcinoma</title>
		<author>
			<persName><forename type="first">Y</forename><surname>Matsuda</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Wakai</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Hirose</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Osawa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Fujimaki</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Kubota</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Int J Mol Sci</title>
		<imprint>
			<biblScope unit="volume">14</biblScope>
			<biblScope unit="page" from="23499" to="23515" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b15">
	<monogr>
		<title/>
		<idno type="DOI">10.3390/ijms141223499</idno>
		<ptr target="http://dx.doi.org/10.3390/ijms141223499" />
		<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b16">
	<analytic>
		<title level="a" type="main">Thyroid hormone-related regulation of gene expression in human fatty liver</title>
		<author>
			<persName><forename type="first">J</forename><surname>Pihlajamaki</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Boes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">Y</forename><surname>Kim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Dearie</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">W</forename><surname>Kim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Schroeder</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Mun</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Nasser</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">J</forename><surname>Park</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">C</forename><surname>Bianco</surname></persName>
		</author>
		<idno type="DOI">10.1210/jc.2009-0212</idno>
		<idno type="PMID">19549744</idno>
		<ptr target="http://dx.doi.org/10.1210/jc.2009-0212" />
	</analytic>
	<monogr>
		<title level="j">J Clin Endocrinol Metab</title>
		<imprint>
			<biblScope unit="volume">94</biblScope>
			<biblScope unit="page" from="3521" to="3529" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b17">
	<analytic>
		<title level="a" type="main">A liver-derived secretory protein, selenoprotein P, causes insulin resistance</title>
		<author>
			<persName><forename type="first">H</forename><surname>Misu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Takamura</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Takayama</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Hayashi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Matsuzawa-Nagata</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Kurita</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Ishikura</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Ando</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Takeshita</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Ota</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.cmet.2010.09.015</idno>
		<idno type="PMID">21035759</idno>
		<ptr target="http://dx.doi.org/10.1016/j.cmet.2010.09.015" />
	</analytic>
	<monogr>
		<title level="j">Cell Metab</title>
		<imprint>
			<biblScope unit="volume">12</biblScope>
			<biblScope unit="page" from="483" to="495" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title level="a" type="main">Reduced hepatic insulin extraction in response to gastric inhibitory polypeptide compensates for reduced insulin secretion in normal-weight and normal glucose tolerant first-degree relatives of type 2 diabetic patients</title>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">N</forename><surname>Rudovich</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">J</forename><surname>Rochlitz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">F</forename><surname>Pfeiffer</surname></persName>
		</author>
		<idno type="DOI">10.2337/diabetes.53.9.2359</idno>
		<idno type="PMID">15331546</idno>
		<ptr target="http://dx.doi.org/10.2337/diabetes.53.9.2359" />
	</analytic>
	<monogr>
		<title level="j">Diabetes</title>
		<imprint>
			<biblScope unit="volume">53</biblScope>
			<biblScope unit="page" from="2359" to="2365" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b19">
	<analytic>
		<title level="a" type="main">Hepatic insulin clearance is closely related to metabolic syndrome components</title>
		<author>
			<persName><forename type="first">O</forename><surname>Pivovarova</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Bernigau</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Bobbert</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Isken</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Mohlig</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Spranger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">O</forename><surname>Weickert</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Osterhoff</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">F</forename><surname>Pfeiffer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Rudovich</surname></persName>
		</author>
		<idno type="DOI">10.2337/dc12-1203</idno>
		<idno type="PMID">24026549</idno>
		<ptr target="http://dx.doi.org/10.2337/dc12-1203" />
	</analytic>
	<monogr>
		<title level="j">Diabetes Care</title>
		<imprint>
			<biblScope unit="volume">36</biblScope>
			<biblScope unit="page" from="3779" to="3785" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b20">
	<analytic>
		<title level="a" type="main">Duckworth WC. Insulin metabolism in human adipocytes from subcutaneous and visceral depots</title>
		<author>
			<persName><forename type="first">J</forename><surname>Fawcett</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Sang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">A</forename><surname>Permana</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">L</forename><surname>Levy</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Biochem Biophys Res Commun</title>
		<imprint>
			<biblScope unit="volume">402</biblScope>
			<biblScope unit="page" from="762" to="766" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b21">
	<monogr>
		<title/>
		<idno type="DOI">10.1016/j.bbrc.2010.10.104</idno>
		<idno type="PMID">21036154</idno>
		<ptr target="http://dx.doi.org/10.1016/j.bbrc.2010.10.104" />
		<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b22">
	<analytic>
		<title level="a" type="main">Glucose inhibits the insulin-induced activation of the insulin-degrading enzyme in HepG2 cells</title>
		<author>
			<persName><forename type="first">O</forename><surname>Pivovarova</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><surname>Gogebakan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">F</forename><surname>Pfeiffer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Rudovich</surname></persName>
		</author>
		<idno type="DOI">10.1007/s00125-009-1350-7</idno>
		<idno type="PMID">19396426</idno>
		<ptr target="http://dx.doi.org/10.1007/s00125-009-1350-7" />
	</analytic>
	<monogr>
		<title level="j">Diabetologia</title>
		<imprint>
			<biblScope unit="volume">52</biblScope>
			<biblScope unit="page" from="1656" to="1664" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b23">
	<analytic>
		<title level="a" type="main">Stem cell antigen-1 localizes to lipid microdomains and associates with insulin degrading enzyme in skeletal myoblasts</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">L</forename><surname>Epting</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">W</forename><surname>King</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Pedersen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Zaman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Ritner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">S</forename><surname>Bernstein</surname></persName>
		</author>
		<idno type="DOI">10.1002/jcp.21500</idno>
		<idno type="PMID">18506847</idno>
		<ptr target="http://dx.doi.org/10.1002/jcp.21500" />
	</analytic>
	<monogr>
		<title level="j">J Cell Physiol</title>
		<imprint>
			<biblScope unit="volume">217</biblScope>
			<biblScope unit="page" from="250" to="260" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b24">
	<analytic>
		<title level="a" type="main">Presenilin-dependent gamma-secretase-mediated control of p53-associated cell death in Alzheimer&apos;s disease</title>
		<author>
			<persName><forename type="first">C</forename><surname>Alves Da Costa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Sunyach</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Pardossi-Piquard</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Sevalle</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Vincent</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Boyer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Kawarai</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Girardot</surname></persName>
		</author>
		<author>
			<persName><forename type="first">St</forename><surname>George-Hyslop</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Checler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename></persName>
		</author>
		<idno type="DOI">10.1523/JNEUROSCI.0651-06.2006</idno>
		<idno type="PMID">16763046</idno>
		<ptr target="http://dx.doi.org/10.1523/JNEUROSCI.0651-06.2006" />
	</analytic>
	<monogr>
		<title level="j">J Neurosci</title>
		<imprint>
			<biblScope unit="volume">26</biblScope>
			<biblScope unit="page" from="6377" to="6385" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b25">
	<analytic>
		<title level="a" type="main">An insulindegrading enzyme inhibitor decreases amylin degradation, increases amylin-induced cytotoxicity, and increases amyloid formation in insulinoma cell cultures</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">G</forename><surname>Bennett</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">G</forename><surname>Hamel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">C</forename><surname>Duckworth</surname></persName>
		</author>
		<idno type="DOI">10.2337/diabetes.52.9.2315</idno>
		<idno type="PMID">12941771</idno>
		<ptr target="http://dx.doi.org/10.2337/diabetes.52.9.2315" />
	</analytic>
	<monogr>
		<title level="j">Diabetes</title>
		<imprint>
			<biblScope unit="volume">52</biblScope>
			<biblScope unit="page" from="2315" to="2320" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b26">
	<analytic>
		<title level="a" type="main">Regulation of protein degradation by insulin-degrading enzyme: analysis by small interfering RNA-mediated gene silencing</title>
		<author>
			<persName><forename type="first">J</forename><surname>Fawcett</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">A</forename><surname>Permana</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">L</forename><surname>Levy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">C</forename><surname>Duckworth</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.abb.2007.09.019</idno>
		<idno type="PMID">17964527</idno>
		<ptr target="http://dx.doi.org/10.1016/j.abb.2007.09.019" />
	</analytic>
	<monogr>
		<title level="j">Arch Biochem Biophys</title>
		<imprint>
			<biblScope unit="volume">468</biblScope>
			<biblScope unit="page" from="128" to="133" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b27">
	<analytic>
		<title level="a" type="main">Elevated hepatic chemerin mRNA expression in human non-alcoholic fatty liver disease</title>
		<author>
			<persName><forename type="first">S</forename><surname>Docke</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">F</forename><surname>Lock</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">L</forename><surname>Birkenfeld</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Hoppe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Lieske</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Rieger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Raschzok</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">M</forename><surname>Sauer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Florian</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Osterhoff</surname></persName>
		</author>
		<idno type="PMID">23935128</idno>
	</analytic>
	<monogr>
		<title level="j">Eur J Endocrinol</title>
		<imprint>
			<biblScope unit="volume">169</biblScope>
			<biblScope unit="page" from="547" to="557" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b28">
	<monogr>
		<title/>
		<idno type="DOI">10.1530/EJE-13-0112</idno>
		<ptr target="http://dx.doi.org/10.1530/EJE-13-0112" />
		<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b29">
	<analytic>
		<title level="a" type="main">American Diabetes A. Diagnosis and classification of diabetes mellitus</title>
	</analytic>
	<monogr>
		<title level="j">Diabetes care</title>
		<imprint>
			<biblScope unit="volume">33</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="S62" to="69" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
	<note>Suppl</note>
</biblStruct>

<biblStruct xml:id="b30">
	<analytic>
		<title level="a" type="main">Analyzing illumina gene expression microarray data from different tissues: methodological aspects of data analysis in the metaxpress consortium</title>
		<author>
			<persName><forename type="first">C</forename><surname>Schurmann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Heim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Schillert</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Blankenberg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Carstensen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Dorr</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Endlich</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">B</forename><surname>Felix</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Gieger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Grallert</surname></persName>
		</author>
		<idno type="DOI">10.1371/journal.pone.0050938</idno>
		<idno type="PMID">23236413</idno>
		<ptr target="http://dx.doi.org/10.1371/journal.pone.0050938" />
	</analytic>
	<monogr>
		<title level="j">PloS one</title>
		<imprint>
			<biblScope unit="volume">7</biblScope>
			<biblScope unit="page">e50938</biblScope>
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b31">
	<monogr>
		<title level="m" type="main">Limma: linear models for microarray data</title>
		<author>
			<persName><forename type="first">R</forename><surname>Gentleman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Carey</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Dudoit</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Irizarry</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Huber</surname></persName>
		</author>
		<imprint>
			<date type="published" when="2005">2005</date>
			<publisher>Springer</publisher>
			<pubPlace>New York</pubPlace>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b32">
	<analytic>
		<title level="a" type="main">Controlling the False Discovery Rate -a Practical and Powerful Approach to Multiple Testing</title>
		<author>
			<persName><forename type="first">Y</forename><surname>Benjamini</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Hochberg</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Roy Stat Soc B Met</title>
		<imprint>
			<biblScope unit="volume">57</biblScope>
			<biblScope unit="page" from="289" to="300" />
			<date type="published" when="1995">1995</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b33">
	<analytic>
		<title level="a" type="main">Changes of dietary fat and carbohydrate content alter central and peripheral clock in humans</title>
		<author>
			<persName><forename type="first">O</forename><surname>Pivovarova</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Jurchott</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Rudovich</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Hornemann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Lu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Mockel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Murahovschi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Kessler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">C</forename><surname>Seltmann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Maser-Gluth</surname></persName>
		</author>
		<idno type="PMID">25822100</idno>
	</analytic>
	<monogr>
		<title level="j">J Clin Endocrinol Metab</title>
		<imprint>
			<date type="published" when="2015">2015. jc20143868</date>
		</imprint>
	</monogr>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
